STMN2 and amyotrophic lateral sclerosis: Using in vitro neuronal models of TDP-43 depletion via knockdown, induction of TDP-43 mislocalisation, and pathological loss of function TDP-43 mutations known to cause ALS, the research groups demonstrated a resultant dramatic reduction in levels of mature STMN2 mRNA and functional protein.